HCW Biologics Inc. - Common Stock (NQ:HCWB)

1.680 -0.010 (-0.59%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HCW Biologics Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

HCWB Stock Earnings: HCW Biologics Reported Results for Q2 2024 ↗

August 14, 2024

HCW Biologics just reported results for the second quarter of 2024.

Via InvestorPlace

HCWB Stock Earnings: HCW Biologics Reported Results for Q1 2024 ↗

May 15, 2024

HCW Biologics just reported results for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 12, 2024

Via Benzinga

HCWB Stock Earnings: HCW Biologics Misses EPS, Misses Revenue for Q4 2023 ↗

April 01, 2024

HCWB stock results show that HCW Biologics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 27, 2023

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.

Via Benzinga

Looking Into HCW Biologics's Return On Capital Employed ↗

March 29, 2023

Via Benzinga

Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

November 08, 2023

From HCW Biologics, Inc

Via GlobeNewswire

Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting

November 01, 2023

HCW9218 is the lead product candidate of HCW Biologics Inc.

From HCW Biologics, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 14, 2023

Via Benzinga

HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023

September 06, 2023

Company will provide an update for clinical development and intellectual property programs, Including recent achievements and expected milestones in the next 12 months

From HCW Biologics, Inc

Via GlobeNewswire

Nerdy And 3 Other Stocks Under $4 Insiders Are Aggressively Buying ↗

June 08, 2023

The Dow Jones closed higher by around 90 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

$3M Bet On This Technology Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

June 01, 2023

The Dow Jones closed lower by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying ↗

May 25, 2023

The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Recap: HCW Biologics Q1 Earnings ↗

May 09, 2023

HCW Biologics (NASDAQ:HCWB) reported its Q1 earnings results on Tuesday, May 9, 2023 at 07:15 AM. Here's what investors need to know about the announcement. Earnings HCW Biologics reported in-line EPS...

Via Benzinga

HCW Biologics: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 27, 2023

Via Benzinga

HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan

April 27, 2023

From HCW Biologics, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 06, 2023

Via Benzinga

Why SeaChange International Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket ↗

April 06, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 15, 2023

Via Benzinga

HCW Biologics Enters CRADA with National Cancer Institute

December 08, 2022

NCI Activated as Clinical Site for Phase 1b/2 Clinical Trial to Evaluate HCW9218 in Advanced Pancreatic Cancer

From HCW Biologics, Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 01, 2022

Via Benzinga

Smith Micro Software And 3 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

August 31, 2022

US crude oil futures traded lower this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022 ↗

November 08, 2022

Upgrades

Via Benzinga

CASI Pharmaceuticals And 2 Other Stocks Under $4 Insiders Are Aggressively Buying ↗

August 29, 2022

The Dow Jones tumbled by over 1,000 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

August 04, 2022

On Thursday, 49 companies reached new 52-week lows.

Via Benzinga

Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday ↗

August 25, 2022

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company.

Via Benzinga

Why Citi Trends Is Trading Lower By 17%, Here Are 47 Stocks Moving In Wednesday's Mid-Day Session ↗

August 24, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 77% to $2.35. Bright Minds priced overnight marketed offering of 2.858 million units at $1.40 per unit.

Via Benzinga

3 Stocks Under $3 Insiders Are Aggressively Buying ↗

June 16, 2022

The Federal Open Market Committee opted to raise fed funds rates by 0.75% on Wednesday to a new target range of between 1.5% and 1.75%. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.